Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Neurodevelopmental Syndrome with Intellectual Disability, Speech Impairment, and Quadrupedia Is Associated with Glutamate Receptor Delta 2 Gene Defect
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
4652290
Author(s)
Grigorenko, Anastasia P.; Protasova, Maria S.; Lisenkova, Alexandra A.; Reshetov, Denis A.; Andreeva, Tatiana V.; Garcias, Gilberto De Lima; Martino Roth, Maria Da Graça; Papassotiropoulos, Andreas; Rogaev, Evgeny I.
Bipedalism, speech, and intellect are the most prominent traits that emerged in the evolution of; Homo sapiens; . Here, we describe a novel genetic cause of an "involution" phenotype in four patients, who are characterized by quadrupedal locomotion, intellectual impairment, the absence of speech, small stature, and hirsutism, observed in a consanguineous Brazilian family. Using whole-genome sequencing analysis and homozygous genetic mapping, we identified genes bearing homozygous genetic variants and found a homozygous 36.2 kb deletion in the gene of glutamate receptor delta 2 (; GRID2; ) in the patients, resulting in the lack of a coding region from the fifth to the seventh exons. The; GRID2; gene is highly expressed in the cerebellum cortex from prenatal development to adulthood, specifically in Purkinje neurons. Deletion in this gene leads to the loss of the alpha chain in the extracellular amino-terminal protein domain (ATD), essential in protein folding and transport from the endoplasmic reticulum (ER) to the cell surface. Then, we studied the evolutionary trajectories of the; GRID2; gene. There was no sign of strong selection of the highly conservative; GRID2; gene in ancient hominids (Neanderthals and Denisovans) or modern humans; however, according to in silico tests using the Mfold tool, the; GRID; 2 gene possibly gained human-specific mutations that increased the stability of; GRID2; mRNA.
